首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   381542篇
  免费   78649篇
  国内免费   6647篇
耳鼻咽喉   6042篇
儿科学   9878篇
妇产科学   6995篇
基础医学   48562篇
口腔科学   13781篇
临床医学   56513篇
内科学   81513篇
皮肤病学   14858篇
神经病学   37033篇
特种医学   16028篇
外国民族医学   21篇
外科学   56758篇
综合类   14304篇
现状与发展   72篇
一般理论   114篇
预防医学   30584篇
眼科学   9482篇
药学   27074篇
  67篇
中国医学   6099篇
肿瘤学   31060篇
  2024年   972篇
  2023年   6705篇
  2022年   6029篇
  2021年   11566篇
  2020年   14270篇
  2019年   17123篇
  2018年   20526篇
  2017年   20875篇
  2016年   22637篇
  2015年   25237篇
  2014年   29606篇
  2013年   33206篇
  2012年   24817篇
  2011年   24718篇
  2010年   24720篇
  2009年   22246篇
  2008年   18362篇
  2007年   16082篇
  2006年   16400篇
  2005年   13925篇
  2004年   11636篇
  2003年   10531篇
  2002年   9247篇
  2001年   8617篇
  2000年   7259篇
  1999年   6429篇
  1998年   4114篇
  1997年   3551篇
  1996年   3474篇
  1995年   3058篇
  1994年   2335篇
  1993年   1887篇
  1992年   2688篇
  1991年   2554篇
  1990年   2152篇
  1989年   2028篇
  1988年   1831篇
  1987年   1604篇
  1986年   1500篇
  1985年   1269篇
  1984年   950篇
  1983年   901篇
  1982年   660篇
  1981年   610篇
  1980年   486篇
  1979年   607篇
  1978年   540篇
  1977年   511篇
  1976年   437篇
  1974年   437篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
24.
25.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion.  相似文献   
26.
Two Janus-associated kinase inhibitors (JAKi) (initially ruxolitinib and, more recently, fedratinib) have been approved as treatment options for patients who have intermediate-risk and high-risk myelofibrosis (MF), with pivotal trials demonstrating improvements in spleen volume, disease symptoms, and quality of life. At the same time, however, clinical trial experiences with JAKi agents in MF have demonstrated a high frequency of discontinuations because of adverse events or progressive disease. In addition, overall survival benefits and clinical and molecular predictors of response have not been established in this population, for which the disease burden is high and treatment options are limited. Consistently poor outcomes have been documented after JAKi discontinuation, with survival durations after ruxolitinib ranging from 11 to 16 months across several studies. To address such a high unmet therapeutic need, various non-JAKi agents are being actively explored (in combination with ruxolitinib in first-line or salvage settings and/or as monotherapy in JAKi-pretreated patients) in phase 3 clinical trials, including pelabresib (a bromodomain and extraterminal domain inhibitor), navitoclax (a B-cell lymphoma 2/B-cell lymphoma 2-xL inhibitor), parsaclisib (a phosphoinositide 3-kinase inhibitor), navtemadlin (formerly KRT-232; a murine double-minute chromosome 2 inhibitor), and imetelstat (a telomerase inhibitor). The breadth of data expected from these trials will provide insight into the ability of non-JAKi treatments to modify the natural history of MF.  相似文献   
27.
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs.  相似文献   
28.
29.
目的:通过调研江苏省公立医院编内及非在编人员参加养老保险的现状,分析其存在的困境,提出相应的对策建议。方法:对江苏省内公立医院发放调研问卷,收集数据整理后运用统计分析和比较分析法描述其运营概况、编内及非在编人员参加养老保险的情况,运用公平理论分析公立医院养老保险存在的问题。结果:江苏省公立医院编内人员参加机关事业单位养老保险,非在编人员参加城镇职工养老保险;省属公立医院非在编人员占比最高;编内人员缴费基数及养老待遇均显著高于非在编人员;编内人员参加职业年金,非在编人员尚未建立年金计划。结论:树立底线公平理念,完善养老保险制度体系;改革完善非在编人员年金计划政策;建立健全参保成本财政分担机制。  相似文献   
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号